Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 70Cyclophosphamide 46Cisplatin 42Nivolumab 33Radiotherapy 30Paclitaxel 30Gemcitabine 30Carboplatin 28Docetaxel 26Dexamethasone 22atezolizumab 20Blood Specimen Collection 20Bevacizumab 19Rituximab 18Radiosurgery 18Fluorouracil 18fludarabine 17Magnetic Resonance Spectroscopy 17Leucovorin 17Lenalidomide 17Surveys and Questionnaires 16Oxaliplatin 16Doxorubicin 15Irinotecan 14Etoposide 14palbociclib 13Vincristine 13Radiotherapy, Intensity-Modulated 13Prednisone 13Letrozole 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × 68Ga-FAPI × 90 days × Clear all
NCT07553741 2026-04-28

Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Completed
27 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡